On the occasion of  the first DIA BioVenture day on 28 March 2017 in Glasgow, Menno Aarnout, Wolfgang Stoiber and EBE's Barbara Freischem discussed options for solutions to support the development and funding of Advanced Therapies and Breakthrough Medicines in Europe.

Listen to the podcast here 

                                                                 
Menno Aarnout                                       Barbara Freischem                             Wolfgang Stoiber
Executive Director                                      Executive Director                               Managing Director
The International Association             European Biopharmaceutical                         JSB Partners
of Mutual Benefit Societies (AIM)               Enterprises (EBE)

Discussions moderated by:

Duane Schulthess
Managing Director 
Vital Transformation

See also the EBE Position Paper 'Europe's flawed and underfunded biotech ecosystem
05 April 2017 in Highlights